Credit Suisse Group (ADR)

  • Foreign Money Center Banks and Minting Your Fortune

    By Chris Hodge - August 7, 2013 | Tickers: BLX, CS, WBK

    Some investors think that currency fluctuations are the worst part of investing foreign stocks, but I think these fluctuations are great opportunities. Why limit yourself to just one currency when it can go down easily? Not to sound like I'm preaching American declinism, but US won't be on top forever and domestic companies aren't necessarily the best ones going. The following might be some good ways to more »

  • How To Play The Mortgage Recovery Safely

    By Bill Edson - March 15, 2013 | Tickers: AGNC, CG, CS, MTG

    There are many ways to play a recovery in the mortgage market, though some angles are more treacherous than others. Investors can choose between REITs (Real Estate Investment Trusts) that specialize in leveraged buying of mortgage debt, financial companies that invest in distressed residential real estate, or mortgage bond insurers.

    Leveraged mREITs

    American Capital Agency (NASDAQ: AGNC) raised $1.58 billion by selling approximately 50 million shares in February 2013 more »

  • Will Legacy Issues Haunt These Stocks Forever?

    By Bill Edson - March 1, 2013 | Tickers: BAC, CS, MBI

    Many financial institutions face legacy issues from precarious loans and mortgages. In particular, reinsurance companies and mortgage banks seem to be endlessly battling over who will take losses. Since valuing these companies is somewhere between challenging and impossible, prudent investors may wish to avoid these companies all together. Speculators who want to bottom fish should be very picky about which stocks they select.

    MBIA complaints about CS mortgages

    MBIA Insurance more »

  • Victoria Gold Corp: A Sleeping Giant Waits

    By Josh Ginsburg - February 2, 2013 | Tickers: ABX, CS, FNV, JPM, KGC, RGLD

    I'll be the first to admit that I am a believer in the long term value of gold and silver. In a US economy that's continuing to grow ever more unstable and vulnerable, one can infer with substantial historical reference that intrinsic value is continuing to shift progressively more into hard assets. In terms of the long term value of gold I think most readers will agree that more »

  • An ETF Giant Gets Bigger

    By Reuben Brewer - January 22, 2013 | Tickers: BCS, BLK, CS

    BlackRock (NYSE: BLK) has moved aggressively to expand its business over the last decade or so. One of its most successful shifts has been to quickly establish itself as a leader in the exchange traded fund market. It isn't done yet, and that's good news for investors.

  • Leading Swiss Banks Navigate Scandals and Shrinking Business

    By Peter Pham - December 7, 2012 | Tickers: CS, PJB.DL, KBE, UBS

    UBS AG (NYSE: UBS), the largest Swiss lender and one of the world’s leading financial institutions was badly hit by the global financial crisis and its ongoing sequel the European Debt Crisis. In October of this year, the bank had announced plans to eliminate 10,000 jobs and implement aggressive cost cutting measures that will reduce expenses $3.6 billion by 2015. Almost half of the layoffs will happen more »

  • What Investors Should Know And Do To Make Sure The Short Interest In Arena's Stock Is Playing By The Rules.

    By Joseph Dedvukaj - November 26, 2012 | Tickers: ARNA, BAC, BCS, SCHW, C, CS, DB, ETFC, GS, HBC, JPM, MFG, NES.DL, PJC, RBS, BA, TST, UBS, WFC

    1. Arena (NASDAQ: ARNA) short-sellers using illegal short and distort-

    As of November 15, 2012, Arena short interest is 61,748,793 shares. This is the highest it has ever been. How much of the short interest is illegal naked shorting? We believe its substantial. It is no secret Arena investors know illegal naked short selling and stock manipulation are being used to manipulate Arena's stock to some extent more »

  • Will Buying Pink Slips In Bulk Help UBS?

    By Meena Krishnamsetty - November 2, 2012 | Tickers: BAC, C, CS, HBC, UBS

    Bank of America (NYSE: BAC) is planning to cut 10% of its workforce, but UBS (NYSE: UBS) thinks it can do better. The Switzerland-based investment bank, which may be best known for its wealth management unit but also includes standard i-bank functions such as trading, has announced that it will cut costs by reducing its headcount by one-sixth, or 10,000 jobs. This comes after a quarter in which the more »

  • Nobel Prize and the Next Biotech Goldmine

    By REZA GANJAVI - October 30, 2012 | Tickers: ARNA, CS, OREX, VVUS

    Earlier this month, the 2012 Nobel Prize in chemistry was granted to two American scientists for their work on a G-Protein Coupled Receptors (GPCRs), a.k.a. "seven-transmembrane domain receptors" which sense external molecules and activate internal signals and cell response. These receptors are linked to a wide range of diseases. Around 70% of all medicines today somehow affect these receptors and most of them were developed without a more »

  • Analysts Objectivity in Coverage of the Obesity Space

    By REZA GANJAVI - October 26, 2012 | Tickers: ARNA, BAC, CS, OREX, VVUS

    Today Orexigen Therapeutics (NASDAQ: OREX) announced a proposed public offering of common stock. Surprise, surprise! Credit Suisse (NYSE: CS)‎ and BofA Merrill Lynch ("ML") (NYSE: BAC) are two of the three book-running managers for the offering. Both Credit Suisse and Merrill Lynch have been promoting Orexigen with what appeared to me to be inflated price targets.

    By the same token, both CS & ML have been wrong in issuing bearish sentiments more »

  • Sly Synergies Push Creative Cost Savings

    By Chris Marasco - October 2, 2012 | Tickers: C, CS, GS, JPM, NES.DL

    One of the biggest and best private banks in the U.S. is JPMorgan’s (NYSE: JPM) asset management unit.  The unit has won numerous awards from an array of publishers proclaiming its competence, professionalism, and creative wherewithal.

    Another major part of the bank’s strength is that it evokes a powerful emotion from its customers: trust.  The clients, who often have assets exceeding $25 million, are shown products from more »

  • Banking Sector Investors Beware: Losses Come With The Territory

    By Bill Edson - October 2, 2012 | Tickers: CS, JPM, UBS

    The market is overreacting to investigations of prominent financial companies. The possibility of such activities going on behind the scenes should have been priced into financial stocks before specific problems arose. Furthermore, the likelihood of more allegations and legal issues coming to light is roughly the same as it was before. As an investor, there is no reason to punish financial stocks that got caught since there is no way more »

  • Risk Management in Financial Institutions Part 2

    By Yasir Idrees - September 17, 2012 | Tickers: BCS, CS, HBC

    Recently, there have been several major losses to some of the biggest financial institutions and banks due to several reasons such as interest rates and credit exposure. Risk management is a type of strategy which every financial institution needs to have at its core and there are several parts involved in this including monitoring the risks, measuring these risks and controlling risks.

    One of the basic risks, which many financial more »

  • Credit Suisse Sets A New Low Standard For Poor Analysis In Their Coverage Of Arena Pharmaceuticals

    By REZA GANJAVI - September 9, 2012 | Tickers: ARNA, CS, OREX, OSTK, VVUS

     [Disclaimer: All the points which are not explicitly attributed to CS are only general statements and should not be considered as being about CS. Issues with CS's report on Arena are listed in the APPENDIX]

    Arena Pharmaceuticals (NASDAQ: ARNA)  is a San Diego, California company which has recently had its drug, Belviq, a potential mega blockbuster approved by the FDA -- the first weight management drug approved in 13 years more »

  • Spotlight on a Tax Haven: Switzerland

    By Alexander MacLennan - August 22, 2012 | Tickers: IRE, CS, NBG, UBS

    What do owners of mass sums of money and movie character Gordon Gekko have in common? They both use Swiss bank accounts to protect their enormous wealth and keep it secret from the public. In the second Wall Street movie, Gekko reveals that he has a $100 million trust set up in Switzerland. While this is just a part of a movie, we may never know just how close to more »

  • HSBC's Strategy is No Occident

    By Nick Slepko - June 20, 2012 | Tickers: CS, HSBA, HBC, LYG, RBS

    Europe’s biggest bank may dominate the continent even more by becoming less European.

    HSBC (LSE: HSBA)(NYSE: HBC) continues to see over three-quarters of its profits coming from outside the troubled North Atlantic Rim.  With less than ten percent originating in its home market, the London-based banking and financial services firm is returning to its international roots with the H (for “Hongkong”) leading the way. The firm’s operations more »

  • Impacts of the Fed's "Big Is Bad" Mentality on BAC

    By Helen Hagan - May 7, 2012 | Tickers: BAC, BCS, C, CS, HBC

    Bank of America (NYSE: BAC) appears to be able to keep its head above water in these financially stressful times.

    Recent reports show that Bank of America shares have outperformed the broader market so far this year. The general belief was that Bank of America would not survive under pressure “even though the company did not include any plans for increases to its dividend or for share buybacks in its more »

  • 8 High Yield Stocks With Buy Rating And Cheap P/E Ratio

    By DividendYields - January 5, 2012 | Tickers: NLY, SAN, BBY, CS, E, SDRL, TEF, TOT, VIP

    As of today, there are 949 companies with a yield of more than 5 percent but high yielding stocks often have a big yield because their dividend is not sustainable and the market expects a dividend cut in the near future. It is very hard to select between good and bad stocks. That's why I've tried to screen the market by interesting high yield stocks.

    I also took more »